Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02708108 · ClinicalTrials.gov registry record · NA
Improving Diet and Exercise in Acute Lymphoblastic Leukemia (IDEAL Weight in ALL)
A NA study, sponsored by Children's Hospital Los Angeles.
- Completed
- Registry status
- NA
- Development phase
- 40
- Enrollment target
NCT02708108 is a NA study that has completed, run by Children's Hospital Los Angeles. The registered enrollment target is 40 participants.
The verdict
NCT02708108, a NA study, has completed, sponsored by Children's Hospital Los Angeles.
- COMPLETED
- Registry status
- NA
- Development phase
- 40 participants
- Enrollment target
Study Summary
This study tests the ability of a focused dietary, exercise, and activity intervention to reduce fat gain during induction therapy for childhood acute lymphoblastic leukemia to improve disease response and reduce toxicity.
Interventions
- BEHAVIORAL Dietary Intervention
- BEHAVIORAL Activity and Exercise Intervention
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 40 participants |
| Start Date | 2016-05 |
| Est. Completion | 2019-12-30 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02708108
The ClinicalTrials.gov registry entry for NCT02708108 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 40 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Children's Hospital Los Angeles, which has 119 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Dietary Intervention is the first listed.
NCT02708108 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02708108 about?
NCT02708108 is a clinical study titled "Improving Diet and Exercise in Acute Lymphoblastic Leukemia (IDEAL Weight in ALL)". This study tests the ability of a focused dietary, exercise, and activity intervention to reduce fat gain during induction therapy for childhood acute lymphoblastic leukemia to improve disease response and reduce toxicity.
What is the current status of trial NCT02708108?
This trial is currently completed. It is a NA study. The enrollment target is 40 participants. The study started on 2016-05. Estimated completion is 2019-12-30.
What interventions are being tested in trial NCT02708108?
The interventions under investigation include: Dietary Intervention (BEHAVIORAL), Activity and Exercise Intervention (BEHAVIORAL).
Who is sponsoring clinical trial NCT02708108?
This trial is sponsored by Children's Hospital Los Angeles, which has 119 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.